Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
26.60
-1.70 (-5.99%)
Dec 3, 2024, 12:19 PM EST - Market open

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $14.27M in the quarter ending September 30, 2024, a decrease of -17.01%. This brings the company's revenue in the last twelve months to $349.64M, up 328.73% year-over-year. In the year 2023, Beam Therapeutics had annual revenue of $377.71M with 520.01% growth.

Revenue (ttm)
$349.64M
Revenue Growth
+328.73%
P/S Ratio
6.62
Revenue / Employee
$801,933
Employees
436
Market Cap
2.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
Premier 1.33B
Addus HomeCare 1.13B
Omnicell 1.06B
Amphastar Pharmaceuticals 723.55M
NovoCure 577.74M
Mirum Pharmaceuticals 307.03M
GeneDx Holdings 267.23M
Revenue Rankings

BEAM News

More News